Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-28

Clinical Trial Update: Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED) [Phase 1]

View source ↗

Summary

Phase 1 completed dose-comparison trial of sitagliptin in adults with Type 2 diabetes mellitus; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Januvia (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2009-07-28